ArticleInternational journal of general medicine2025
Identification of Ferroptosis-Related Genes in Patients with Renal Ischemia-Reperfusion Injury.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferroptosis in ischemia-reperfusion injury: molecular mechanisms and therapeutic strategies.American journal of cardiovascular disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During acute kidney injury, hypoxic injury following reactive oxygen species (ROS) production due to reoxidation leads to severe inflammation and ferroptosis. Thus, the aim of the current research was to determine the ferroptosis-related biomarkers in IRI injury. Methods: GSE43974 dataset was analyzed to identify differentially expressed genes (DEGs) using bioinformatics analysis. The intersection of DEGs and ferroptosis-related genes was identified as differentially expressed ferroptosis-related genes (DEFRGs). Finally, a renal ischemia-reperfusion model was made using mice, and the model was identified by HE staining and markers of IRI, including BUN and Scr. Changes in the expression of hub gene in the model and sham groups were detected by RT-pcr. Results: A total of 3950 DEGs were identified between the IRI and control samples. Thereafter, 74 DEFRGs are obtained by taking the intersection of DEGs and ferroptosis-related genes. The GO analysis indicated that DEFRGs were mainly enriched in response to oxidative stress-related pathway. By MCODE, ATF3, ATF4, ATG3, ATG5, BECN1, DDIT3, HSPA5, NFE2L2, WIPI1, XBP1 were identified as hub genes. ATF3, DDIT3, ATF4, and ATG3 with AUC more than 0.7 were identified as biomarkers. It was confirmed by RT-pcr that the expression of hub genes ATF3, DDIT3, ATF4 was significantly elevated, and the expression of ATG3 was significantly reduced in the IRI model group. It was consistent with the expected results of data analysis in GEO. Conclusion: In conclusion, our study identified 4 ferroptosis-related hub genes in the IRI and demonstrated that they are potential diagnostic biomarkers for IRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.